Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)
NCT00526552 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2010-03-30
Summary
To evaluate the efficacy of rosuvastatin in Korean dyslipidemia patients with diabetes
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Hyunah Caroline Choi · AstraZeneca Korea
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2007-08-31
- Completion
- 2007-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Effect of Crestor on Lipoprotein Metabolism in Humans
NCT00214617 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
NCT02280590 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline
NCT03903029 ·Status: COMPLETED
-
Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
NCT04829149 ·Status: COMPLETED
-
Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 Diabetes
NCT02185963 ·Status: COMPLETED ·Phase: PHASE4
-
Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions
NCT01241903 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome
NCT00815659 ·Status: COMPLETED ·Phase: PHASE4
-
DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia
NCT00241488 ·Status: COMPLETED ·Phase: PHASE3
-
JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events
NCT00239681 ·Status: TERMINATED ·Phase: PHASE3
-
High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension
NCT03474562 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk
NCT02482207 ·Status: COMPLETED ·Phase: PHASE4
-
High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes
NCT03403556 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia
NCT03217409 ·Status: COMPLETED ·Phase: PHASE4
-
Vascular and Metabolic Effects of Rosuvastatin
NCT01660919 ·Status: COMPLETED ·Phase: PHASE4
-
Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and Efficacy
NCT03742544 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of CREZET Tablet
NCT05889143 ·Status: ACTIVE_NOT_RECRUITING
-
PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin
NCT01975961 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects
NCT03175835 ·Status: COMPLETED ·Phase: PHASE1
-
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
NCT01352897 ·Status: COMPLETED
-
Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)
NCT00240266 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.
NCT01982461 ·Status: UNKNOWN ·Phase: NA
-
STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges
NCT00654537 ·Status: COMPLETED ·Phase: PHASE3
-
Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event
NCT00347217 ·Status: COMPLETED
-
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease
NCT00296374 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia
NCT06293261 ·Status: COMPLETED